Arena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS) are going head to head with the goal of trimming pounds off of the citizens of the United States. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened at $5.82 in last session, and closed at $6.00, while the day range of ARNA stock is $5.76 – $6.07. The stock showed a negative weekly performance of -5.21%.
Athersys, Inc. (NASDAQ:ATHX) and Pfizer, Inc. (PFE), after starting out with carefully chosen steps, are nearing completion of a phase II trial for investigating a potential new treatment for Inflammatory Bowel Disease (IBD). Athersys, Inc. (NASDAQ:ATHX) stock opened at $3.41, in last session and closed at $3.79, by gaining 13.47%. The 52 week range of ATHX is $1.42 – $4.33. Company’s market capitalization is $228.25million.
Swiss drug multinational Roche Holding Ltd (VTX:ROG) has won an injunction from the Delhi High Court banning Biocon Ltd (BIOCON) and Mylan Inc. (NASDAQ:MYL) from selling “bio-similar” versions of its breast cancer drug, Herceptin. Mylan Inc (NASDAQ:MYL) stock advanced 3.66% and finished the last session at $45.08. The EPS of the stock remained 1.52. Company’s market capitalization is $17.25billion.
Eli Lilly & Co. (NYSE:LLY)’s stock had its “neutral” rating reiterated by Zacks in a research report issued on Tuesday. Eli Lilly & Co. (NYSE:LLY) stock opened the session at $52.81, and closed the session at $53.21. The 52 week range of the LLY stock remained $47.53 – $58.40 and the day range was $52.75 – $53.55.